Cite

HARVARD Citation

    Shiota, M. et al. (2020). Impact of antiandrogen withdrawal syndrome in castration‐resistant prostate cancer patients treated with abiraterone or enzalutamide. International journal of urology. pp. 1109-1115. [Online]. 
  
Back to record